EUCTR2007-000658-30-IE进行中（未招募）不适用
Randomised controlled trial of Intravitreal Bevacizumab vs. conventional treatment for proliferative diabetic retinopathy. - Randomised controlled trial of Intravitreal Bevacizumab vs. conventional treatment for proliferative
Royal Victoria Eye and Ear hospital0 个研究点目标入组 20 人开始时间: 2007年2月7日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •20 patients with new onset, bilateral, high risk proliferative diabetic retinopathy (DRS criteria) will be recruited.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Women of childbearing potential
研究者
相似试验
进行中（未招募）
不适用
Randomised controlled trial of intravitreal Bevacizumab vs. conventional treatment for rubeotic glaucoma. - Randomised controlled trial of intravitreal Bevacizumab vs. conventional treatment for rubeotic glauRubeotic glaucoma secondary to ischaemic proliferative retinopathiesEUCTR2007-000585-21-IERoyal Victoria Eye and Ear hospital20
进行中（未招募）
不适用
Comparison between injections into the eye ( drug Avastin) with 'pretend' injections in diabetic patients in whom no further treatment is currently available in clinic when they have developed swelling of the centre of the macular associated with lack of blood supply.Ischaemic Diabetic Macular OedemaMedDRA version: 14.1Level: LLTClassification code 10057934Term: Diabetic macular edemaSystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: PTClassification code 10012689Term: Diabetic retinopathySystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: PTClassification code 10012688Term: Diabetic retinal oedemaSystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: PTClassification code 10012661Term: Diabetic eye diseaseSystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: LLTClassification code 10054372Term: Diabetic retinal edemaSystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: LLTClassification code 10038925Term: Retinopathy diabeticSystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: LLTClassification code 10057915Term: Diabetic macular oedemaSystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: HLTClassification code 10012657Term: Diabetic complications ophthalmicSystem Organ Class: 10014698 - Endocrine disordersMedDRA version: 14.1Level: LLTClassification code 10054109Term: Non-proliferative diabetic retinopathySystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: HLGTClassification code 10012653Term: Diabetic complicationsSystem Organ Class: 10014698 - Endocrine disordersEUCTR2011-003304-20-GBMoorfields Eye Hospital NHS Foundation Trust
已完成
不适用
Rondomized prospective trials of intravitreal bevacizumab alone versus combined with photocoagulation for ischmic lesion in retinal venous occlusion.macular edema due to branch retinal vein occlusionJPRN-UMIN000009689Department of Ophthalmology, Faculty of Medical Sciences, University of Fukui40
未知
1 期
To evaluate safety and efficacy of intravitreal Bevaxizumab injection for intraocular neovasculalizatioARMD,BRVO,CRVO,DR,CNVJPRN-UMIN000000647Department of Ophtalmology of Keio University Hospital10
进行中（未招募）
1 期
Randomised Controlled Trial Of Intravitreal Triamcinolone In Patients With Diabetic Macular Oedema Refractory To Laser TreatmentDiabetic macular oedema affecting vision and refractory to laser treatmentEUCTR2005-000397-45-GBQueen's Medical centre40